These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15911340)

  • 1. How can the mood stabilizer VPA limit both mania and depression?
    Cheng L; Lumb M; Polgár L; Mudge AW
    Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
    Di Daniel E; Cheng L; Maycox PR; Mudge AW
    Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG; Watterson JM; Lenox RH
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
    Stoll AL; Severus WE
    Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common mechanism of action for three mood-stabilizing drugs.
    Williams RS; Cheng L; Mudge AW; Harwood AJ
    Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
    Bowden C
    J Affect Disord; 2004 Apr; 79 Suppl 1():S9-14. PubMed ID: 15121342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate decreases inositol biosynthesis.
    Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
    Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
    Harwood AJ
    Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.
    Di Daniel E; Kew JN; Maycox PR
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1139-43. PubMed ID: 19754467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
    Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood stabilizers: protecting the mood...protecting the brain.
    Brunello N
    J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
    Valvassori SS; Rezin GT; Ferreira CL; Moretti M; Gonçalves CL; Cardoso MR; Streck EL; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Oct; 44(14):903-9. PubMed ID: 20334877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
    Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
    Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
    Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
    Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity.
    Di Daniel E; Glover CP; Grot E; Chan MK; Sanderson TH; White JH; Ellis CL; Gallagher KT; Uney J; Thomas J; Maycox PR; Mudge AW
    Mol Cell Neurosci; 2009 Jul; 41(3):373-82. PubMed ID: 19332125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
    Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
    Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.